University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Knowledge Base > Cardiac Risk > Cardiac Risk: Related Resources
Managing Medical Conditions Associated with Cardiac Risk in Patients with HIV: Related Resources
transparent gif
Back to Chapter
arrow imageRelated Knowledge Base Chapters
arrow imageJournal Articles
arrow imageGuidelines and Best Practices
arrow imageConference Reports and Proceedings
arrow imagePresentations, Interviews, and Roundtable Discussions
arrow imageOnline Books and Chapters
arrow imageClinician Support Tools
arrow imagePatient and Community Education
arrow imageLinks
grey line
Related Knowledge Base Chapters
Managing Medical Conditions Associated with Cardiac Risk in Patients with HIV
Daniel Wlodarczyk, MD, August 2004.
Journal Articles
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons
Rotger M, Glass TR, Junier T, et al; MAGNIFICENT Consortium; INSIGHT; Swiss HIV Cohort Study. Clin Infect Dis. 2013 Jul;57(1):112-21.
HIV infection and the risk of acute myocardial infarction
Freiberg MS, Chang CC, Kuller LH, et al. JAMA Intern Med. 2013 Apr 22;173(8):614-22.
HIV and coronary heart disease: time for a better understanding
Boccara F, Lang S, Meuleman C, Ederhy S, et al. J Am Coll Cardiol. 2013 Feb 5;61(5):511-23. Review.
Provider compliance with guidelines for management of cardiovascular risk in HIV-infected patients
Lichtenstein KA, Armon C, Buchacz K, et al; HOPS Investigators. Prev Chronic Dis. 2013 Jan;10:E10.
Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis
Islam FM, Wu J, Jansson J, et al. HIV Med. 2012 Sep;13(8):453-68. Review.
Population-based study of risk factors for coronary heart disease among HIV-infected persons
Oh JY, Greene K, He H, et al. Open AIDS J. 2012;6:177-80.
HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults
Lipshultz SE, Mas CM, Henkel JM, et al. Expert Rev Anti Infect Ther. 2012 Jun;10(6):661-74. Review.
Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population
D'Agostino RB Sr. J Infect Dis. 2012 Jun;205 Suppl 3:S362-7. Review.
HIV infection and coronary heart disease: an intersection of epidemics
Triant VA. J Infect Dis. 2012 Jun;205 Suppl 3:S355-61. Review.
Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy
D'Ascenzo F, Cerrato E, Biondi-Zoccai G, et al. Eur Heart J. 2012 Apr;33(7):875-80. Review.
Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)
Worm SW, De Wit S, Weber R, et at. Circulation. 2009 Feb 17;119(6):805-11.
Guidelines and Best Practices
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
Nathan DM, Buse JB, Davidson MB, et al. Diabetologia. 2009 Jan;52(1):17-30.
Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. NIH Publication No. 02-5215. September 2002.
Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.
Rosendorff C, Black HR, Cannon CP, et al. Circulation. 2007 May 29;115(21):2761-88.
Conference Reports and Proceedings
CROI 2013: Cardiovascular Disease and Comorbidities in HIV
David Shepp, MD; National AIDS Treatment Advocacy Project; 2013.

A summary of studies on the topic of HIV-CVD comorbidities presented at the 20th Conference on Retroviruses and Opportunistic Infections in Atlanta, March 3-6, 2013.

Presentations, Interviews, and Roundtable Discussions
Cardiovascular Risk and Dyslipidemia Management in HIV-Infected Patients
Topics in Antiviral Medicine; IAS-USA; October/November 2012.

Summary of a presentation by James H. Stein, MD, at the IAS-USA live continuing medical education activity held in New York City in March 2012.

Online Books and Chapters
Coronary Heart Disease Risk Chapter: Clinical Manual for Management of the HIV-Infected Adult
AIDS Education and Training Centers National Resource Center; 2014.
Dyslipidemia Chapter: Clinical Manual for Management of the HIV-Infected Adult
AIDS Education and Training Centers National Resource Center; 2014.
Insulin Resistance and Hyperglycemia on Antiretroviral Therapy Chapter: Clinical Manual for Management of the HIV-Infected Adult
AIDS Education and Training Centers National Resource Center; 2014.
Primary Care of Veterans with HIV
A practical approach to the screening and treatment of comorbid conditions, including diabetes and hypertension, in people with HIV. U.S. Department of Veterans Affairs; 2009.
Clinician Support Tools
Database of Antiretroviral Drug Interactions
HIV InSite's fully referenced searchable database of interactions involving at least one antiretroviral drug. Provides information regarding effects on drug levels, potential clinical effects, mechanisms of interaction, management tips, and suggested alternative agents.
Risk Assessment Tool for Estimating 10-Year Risk of Developing Hard CHD
National Cholesterol Education Program, 2002, updated 2004.
Patient and Community Education
HIV and Cardiovascular Disease (Heart Disease)
American Heart Association; updated March 2012.

Webpage includes educational videos for patients and a wellness checklist for cardiovascular risk factors.

HIV-CVD Collaborative
Funded by the National Heart, Lung, and Blood Institute to foster collaborative research into the mechanisms of HIV infection and ART and their relationship to cardiovascular disease risk.